Tandem Diabetes Care TNDM EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Tandem Diabetes Care’s reported figures.
Based on trailing twelve months.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's EBITDA margin?
- Tandem Diabetes Care (TNDM) reported EBITDA margin of -6.4% in Q1 2026.
- How has Tandem Diabetes Care's EBITDA margin changed year-over-year?
- Tandem Diabetes Care's EBITDA margin increased by 60.9% year-over-year, from -16.4% to -6.4%.
- What is the long-term trend for Tandem Diabetes Care's EBITDA margin?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's EBITDA margin has grown at a 101.8% compound annual growth rate (CAGR), from 0.5% to -16.7%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.